Your browser doesn't support javascript.
loading
DNAM-1 expression marks an alternative program of NK cell maturation.
Martinet, Ludovic; Ferrari De Andrade, Lucas; Guillerey, Camille; Lee, Jason S; Liu, Jing; Souza-Fonseca-Guimaraes, Fernando; Hutchinson, Dana S; Kolesnik, Tatiana B; Nicholson, Sandra E; Huntington, Nicholas D; Smyth, Mark J.
Affiliation
  • Martinet L; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse 31000, France.
  • Ferrari De Andrade L; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; Células Inflamatórias e Neoplásicas group, Universidade Federal do Paraná, Curitiba, Paraná 81530-001, Brazil.
  • Guillerey C; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • Lee JS; Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • Liu J; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • Souza-Fonseca-Guimaraes F; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • Hutchinson DS; Department of Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical, Sciences, Monash University, 399 Royal Parade, Parkville, VIC 3052, Australia.
  • Kolesnik TB; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3050, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Nicholson SE; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3050, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Huntington ND; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3050, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, University of Queensland, Herston, QLD 4006, Australia. Electronic address: mark.smyth@qimrberghofer.edu.au.
Cell Rep ; 11(1): 85-97, 2015 Apr 07.
Article in En | MEDLINE | ID: mdl-25818301
ABSTRACT
Natural killer (NK) cells comprise a heterogeneous population of cells important for pathogen defense and cancer surveillance. However, the functional significance of this diversity is not fully understood. Here, we demonstrate through transcriptional profiling and functional studies that the activating receptor DNAM-1 (CD226) identifies two distinct NK cell functional subsets DNAM-1(+) and DNAM-1(-) NK cells. DNAM-1(+) NK cells produce high levels of inflammatory cytokines, have enhanced interleukin 15 signaling, and proliferate vigorously. By contrast, DNAM-1(-) NK cells that differentiate from DNAM-1(+) NK cells have greater expression of NK-cell-receptor-related genes and are higher producers of MIP1 chemokines. Collectively, our data reveal the existence of a functional program of NK cell maturation marked by DNAM-1 expression.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Antigens, Differentiation, T-Lymphocyte / Cell Lineage Limits: Humans Language: En Journal: Cell Rep Year: 2015 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Antigens, Differentiation, T-Lymphocyte / Cell Lineage Limits: Humans Language: En Journal: Cell Rep Year: 2015 Document type: Article Affiliation country: France